Concepedia

Nayeon Kim

NK

Statistics

Publications

8

Citations

213

H-Index

8

Active since

2013

Affiliations

National Cancer Center(Current)

Dongguk University

Korea University

Yonsei University

Osong Medical Innovation Foundation

Nayeon Kim is an author at National Cancer Center specializing in life sciences, molecular oncology, and enzyme inhibition.

ORCID

Publications per year

2013–2024

8

Publications

8

Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor

Seon-Hyeong Lee, Nayeon Kim, Se Jin Kim · Journal of Cancer Research and Clinical Oncology · 2013 · 47 citations · Full text

, , +9

The BDNF Val66Met Polymorphism Affects the Vulnerability of the Brain Structural Network

Chang-Hyun Park, Jungyoon Kim, Eun Namgung et al. · Frontiers in Human Neuroscience · 2017 · 44 citations · Full text

, , +17

Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition

Seon-Hyeong Lee, Won‐Kyu Lee, Nayeon Kim et al. · Cancers · 2018 · 32 citations · Full text

, , +14

A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations

Seong A Kim, Seohyun Kim, Gi Beom Kim et al. · International Journal of Molecular Sciences · 2022 · 20 citations · Full text

, , +17

Inter-molecular crosslinking activity is engendered by the dimeric form of transglutaminase 2

Nayeon Kim, Won‐Kyu Lee, Seon-Hyeong Lee et al. · Amino Acids · 2016 · 19 citations

, , +10

1–5 of 8